Dr. Rosenson is professor of medicine and cardiology at the Icahn School of Medicine, and director of Metabolism and Lipids for the Mount Sinai Health System. He is an American Board of Internal Medicine-certified cardiologist and a member of many cardiovascular organizations and medical societies.
In his research endeavors, Dr. Rosenson is internationally recognized for his investigation on the effects of novel lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis and rheology. His laboratory was the first to demonstrate that stains reduce pro-inflammatory cytokine production.